BioSpace News Archive

Drug Development

Immunic Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of IMU-838, an Oral Therapy for Patients with Relapsing-Remitting Multiple Sclerosis

Immunic AG announced enrollment of the first patient in a phase 2 clinical study of IMU-838 for the treatment of patients with relapsing-remitting multiple sclerosis.

February 26, 2019
·
8 min read
Drug Development

Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers

Medigene AG announced that it has dosed the first patient in its first-in-human clinical trial with its TCR therapy candidate MDG1011.

February 26, 2019
·
6 min read
Business

Actor Scott Foley and TESARO Team Up to Empower Ovarian Cancer Care Partners Through New Phase of Not on My Watch Movement

In a New Public Service Announcement, Foley Reveals for the First Time his Personal Story of Caring for his Mother Following Ovarian Cancer Recurrence

February 26, 2019
·
6 min read
FDA

Medtronic Resolute(TM) Drug-Eluting Stent (DES) Platform Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO)

FDA Approval Allows Interventional Cardiologists Access to Resolute DES Technology to Treat De Novo CTO

February 26, 2019
·
3 min read
Business

Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results

Two pivotal Phase 3 studies of sparsentan progressing on-track to enable potential first-in-class treatment for both FSGS and IgAN

February 26, 2019
·
18 min read
Job Trends

Why a Common Antibiotic Treating Diarrhea is Failing

In the world of superbugs Clostridioides difficile, a bacterium that causes diarrhea and colitis, is among the most stubborn.

February 26, 2019
·
2 min read